|
Volumn 566, Issue 1-3, 2004, Pages 35-38
|
Bisperoxovanadium compounds are potent PTEN inhibitors
|
Author keywords
bpV; bpV(bipy), potassium bisperoxo(bipyridine)oxovanadate; bpV(HOpic), dipotassium bisperoxo(5 hydroxypyridine 2 carboxyl)oxovanadate; bpV, bisperoxovanadate; Insulin mimetic; PI 3 kinase; PKB Akt; PTEN; Small molecule inhibitor
|
Indexed keywords
PHOSPHATIDYLINOSITOL 3 KINASE;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
PROTEIN KINASE B;
SERINE;
VANADIUM DERIVATIVE;
ANIMAL CELL;
ARTICLE;
CONCENTRATION (PARAMETERS);
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SCREENING;
ENZYME PHOSPHORYLATION;
IN VIVO CULTURE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
CELL SURVIVAL;
CHROMONES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENZYME INHIBITORS;
FIBROBLASTS;
HUMANS;
INHIBITORY CONCENTRATION 50;
INSULIN;
MICE;
MORPHOLINES;
NIH 3T3 CELLS;
PHOSPHORIC MONOESTER HYDROLASES;
PHOSPHORYLATION;
PROTEIN-SERINE-THREONINE KINASES;
PROTEIN-TYROSINE-PHOSPHATASE;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-AKT;
PTEN PHOSPHOHYDROLASE;
RECOMBINANT PROTEINS;
TUMOR SUPPRESSOR PROTEINS;
TYROSINE;
VANADIUM COMPOUNDS;
|
EID: 2442601508
PISSN: 00145793
EISSN: None
Source Type: Journal
DOI: 10.1016/j.febslet.2004.03.102 Document Type: Article |
Times cited : (199)
|
References (39)
|